|
|
||||||||
JPPR 1997; 6:307-314
Copyright © 1997 by American Psychiatric Press
REGULAR ARTICLES |
SG Lazar and GO Gabbard
Department of Psychiatry of Georgetown University School of Medicine, Washington, D.C., USA.
Recent studies suggest that psychotherapy can be cost-effective, especially for certain patient populations. These patients include, among others, those with schizophrenia, those with borderline personality disorder, and certain child patients, as well as certain medical patients with concomitant psychiatric illness. In addition, several surveys and actuarial studies suggest better outcomes and cost savings are attained when psychotherapy is available as medically necessary without arbitrary restrictions.
This article has been cited by other articles:
![]() |
L. A. Mellman and E. Beresin Psychotherapy Competencies: Development and Implementation Acad Psychiatry, September 1, 2003; 27(3): 149 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abbass Drug marketing priorities Can. Med. Assoc. J., January 21, 2003; 168(2): 149 - 149. [Full Text] [PDF] |
||||
![]() |
Y. Burnand, A. Andreoli, E. Kolatte, A. Venturini, and N. Rosset Psychodynamic Psychotherapy and Clomipramine in the Treatment of Major Depression Psychiatr Serv, May 1, 2002; 53(5): 585 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Goin Practical Psychotherapy: Borderline Personality Disorder:The Importance of Establishing a Treatment Framework Psychiatr Serv, February 1, 2001; 52(2): 167 - 168. [Full Text] [PDF] |
||||
![]() |
Treatment for Major Depression in Managed Care and Fee-for-Service Systems Am J Psychiatry, July 1, 1998; 155(7): 859 - 860. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |